ReviewJournal of virology2026
The cervicovaginal microbiome: an emerging determinant of HPV infection and disease.
Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Human papillomaviruses (HPVs) are epitheliotropic viruses that cause diseases ranging from cutaneous warts to invasive cancers. HPVs exhibit tropism for the epithelial lining of the skin, oral cavity, and anogenital tract. A subset of HPVs, known as high-risk HPVs, have oncogenic potential and cause nearly one-third of all virus-associated cancers worldwide, including essentially all cervical cancers, most other anogenital cancers, and a growing percentage of head and neck cancers. A large and growing body of clinical and epidemiological research has established the host microbiome, or the collection of microorganisms on and within the body, as a key determinant of HPV infection, persistence, and disease development. In this review, an overview of the current understanding of associations between bacterial components of the host cervicovaginal microbiome (CVM) and aspects of HPV pathogenesis is discussed. Potential mechanisms through which the CVM influences HPV infection and neoplastic disease development are also presented. The inherent challenges of studying HPVs and the microbiome have impeded progress to define not only the underlying mechanisms involved in HPV-CVM interactions, but also the ability to address remaining questions such as causality, temporal dynamics, and the directionality of this relationship. Emerging
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.